NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,248 | +18.5% | 1,504 | 0.0% | 0.00% | – |
| Q1 2023 | $1,053 | +3.3% | 1,504 | -24.8% | 0.00% | – |
| Q4 2022 | $1,019 | +1.9% | 2,001 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,001 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -88.2% | 2,001 | -77.3% | 0.00% | – |
| Q1 2022 | $17,000 | +466.7% | 8,800 | +1157.1% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 700 | +600.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|